# Exparel as a Nerve Block for Severe Hand Pain

> **NCT02374320** · PHASE2,PHASE3 · TERMINATED · sponsor: **Jose Soberon, MD** · enrollment: 13 (actual)

## Conditions studied

- CREST Syndrome
- Peripheral Vascular Disease
- Raynaud Disease
- Scleroderma, Diffuse

## Interventions

- **DRUG:** liposomal bupivacaine

## Key facts

- **NCT ID:** NCT02374320
- **Lead sponsor:** Jose Soberon, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-11
- **Primary completion:** 2016-03
- **Final completion:** 2016-03
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** PI leaving institution
- **Last updated:** 2024-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02374320

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02374320, "Exparel as a Nerve Block for Severe Hand Pain". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT02374320. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*